Androgens: Clinical Research and Therapeutics, a new peer-reviewed, open access journal dedicated to testosterone and other androgens, is now accepting submissions for publication in 2020. The journal aims to publish the highest-quality peer-reviewed articles from all disciplines of medicine, bringing together the numerous areas of testosterone and other androgens clinical research that previously have been dispersed over multiple specialty journals.
Androgens is spearheaded by Editor-in-Chief Dr. Abdul Traish and Senior Editor Dr. Abraham Morgentaler, and is the official journal of the Androgen Society. The journal is supported by an international editorial board of world-renowned researchers and will publish under the Creative Commons Attribution 4.0 (CC-BY and CC-BY-NC) licenses to ensure broad dissemination and participation.
Androgens will publish critical research articles, reviews, case reports, and other contributions related to testosterone deficiency and its treatment in diverse patient populations, including transgender patients, and spanning multiple specialties, such as urology, diabetes, metabolism, and endocrinology.
Authors will now be able to submit articles to the Journal for consideration. Submit your research today or choose to learn more about the Journal.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
Click here to read the original press release.
